Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 59
- Press Release
- Press Release PharmAbcine Announces Japan Patent Registration for PMC-403
- PharmAbcine
- 29 Feb 2024
- Views280
- 0
- 58
- Press Release
- Press Release PharmAbcine's PMC-403 Receives FDA Orphan Drug Designation for Idiopathic Systemic Capillary Leak Syndrome
- PharmAbcine
- 20 Feb 2024
- Views300
- 0
- 57
- Press Release
- Press Release PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDAยฎ (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors
- PharmAbcine
- 24 Jan 2024
- Views772
- 0
- 56
- Press Release
- Press Release PharmAbcineโs Phase 1 Ophthalmology Program PMC-403 Selected by the KDDF for Government-initiated Drug Development Program
- PharmAbcine
- 6 Dec 2023
- Views1121
- 0
- 55
- Press Release
- Press Release PharmAbcine Publishes Study in Science Advances Demonstrating the Potential of PMC-403 in Preclinical Models of Idiopathic Systemic Capillary Leak Syndrome
- PharmAbcine
- 23 Nov 2023
- Views1035
- 0
- 54
- Press Release
- Press Release PharmAbcine Receives Safety Review Committee Approval to Advance to Dose Level 2 of Clinical Trial of PMC-403 with Neovascular Age-related Macular Degeneration following Dose Level 1 Safety Data
- PharmAbcine
- 9 Nov 2023
- Views1388
- 0
- 53
- Press Release
- Press Release PharmAbcine Receives HREC Approval in Australia for the Phase 1a/b Trial of Its Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDAยฎ (pembrolizumab)
- PharmAbcine
- 18 Sep 2023
- Views1621
- 0
- 52
- Press Release
- Press Release PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD
- PharmAbcine
- 24 May 2023
- Views2312
- 0
- 51
- Press Release
- Press Release PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDAยฎ (pembrolizumab)
- PharmAbcine
- 13 Dec 2022
- Views2647
- 0
- 50
- Press Release
- Press Release PharmAbcine to Participate in the 41th Annual J.P. Morgan Healthcare Conference and Biotech Showcaseโข 2023 during JPM Week
- PharmAbcine
- 9 Dec 2022
- Views1605
- 0